327 related articles for article (PubMed ID: 22782417)
1. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
[TBL] [Abstract][Full Text] [Related]
2. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
Anesthesiology; 1995 Oct; 83(4):658-73. PubMed ID: 7574044
[TBL] [Abstract][Full Text] [Related]
3. Predictors of contemporary coronary artery bypass grafting outcomes.
Weisel RD; Nussmeier N; Newman MF; Pearl RG; Wechsler AS; Ambrosio G; Pitt B; Clare RM; Pieper KS; Mongero L; Reece TL; Yau TM; Fremes S; Menasché P; Lira A; Harrington RA; Ferguson TB;
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2720-6.e1-2. PubMed ID: 25218533
[TBL] [Abstract][Full Text] [Related]
4. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
Mangano DT
JAMA; 1997 Jan 22-29; 277(4):325-32. PubMed ID: 9002496
[TBL] [Abstract][Full Text] [Related]
5. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
[TBL] [Abstract][Full Text] [Related]
6. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.
Menasché P; Jamieson WR; Flameng W; Davies MK
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1096-106. PubMed ID: 7475138
[TBL] [Abstract][Full Text] [Related]
7. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
Leung JM; Stanley T; Mathew J; Curling P; Barash P; Salmenpera M; Reves JG; Hollenberg M; Mangano DT
Anesth Analg; 1994 Mar; 78(3):420-34. PubMed ID: 7818622
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
; Alexander JH; Emery RW; Carrier M; Ellis SJ; Mehta RH; Hasselblad V; Menasche P; Khalil A; Cote R; Bennett-Guerrero E; Mack MJ; Schuler G; Harrington RA; Tardif JC
JAMA; 2008 Apr; 299(15):1777-87. PubMed ID: 18381567
[TBL] [Abstract][Full Text] [Related]
9. Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial.
Liakopoulos OJ; Kuhn EW; Hellmich M; Kuhr K; Krause P; Reuter H; Thurat M; Choi YH; Wahlers T;
Am Heart J; 2015 Jul; 170(1):46-54, 54.e1-2. PubMed ID: 26093863
[TBL] [Abstract][Full Text] [Related]
10. Acadesine: a unique cardioprotective agent for myocardial ischemia.
Nawarskas JJ
Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
[TBL] [Abstract][Full Text] [Related]
11. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
Verrier ED; Shernan SK; Taylor KM; Van de Werf F; Newman MF; Chen JC; Carrier M; Haverich A; Malloy KJ; Adams PX; Todaro TG; Mojcik CF; Rollins SA; Levy JH;
JAMA; 2004 May; 291(19):2319-27. PubMed ID: 15150203
[TBL] [Abstract][Full Text] [Related]
12. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
[TBL] [Abstract][Full Text] [Related]
13. Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial.
Møller CH; Perko MJ; Lund JT; Andersen LW; Kelbæk H; Madsen JK; Winkel P; Gluud C; Steinbrüchel DA
Heart; 2011 Jun; 97(11):907-13. PubMed ID: 21415073
[TBL] [Abstract][Full Text] [Related]
14. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.
Goldman S; Sethi GK; Holman W; Thai H; McFalls E; Ward HB; Kelly RF; Rhenman B; Tobler GH; Bakaeen FG; Huh J; Soltero E; Moursi M; Haime M; Crittenden M; Kasirajan V; Ratliff M; Pett S; Irimpen A; Gunnar W; Thomas D; Fremes S; Moritz T; Reda D; Harrison L; Wagner TH; Wang Y; Planting L; Miller M; Rodriguez Y; Juneman E; Morrison D; Pierce MK; Kreamer S; Shih MC; Lee K
JAMA; 2011 Jan; 305(2):167-74. PubMed ID: 21224458
[TBL] [Abstract][Full Text] [Related]
15. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale.
Mehta RH; Alexander JH; Emery R; Ellis SJ; Hasselblad V; Khalil A; Carrier M; Harrington RA; Tardif JC;
Am Heart J; 2008 Apr; 155(4):600-8. PubMed ID: 18371465
[TBL] [Abstract][Full Text] [Related]
17. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
[TBL] [Abstract][Full Text] [Related]
19. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
Holdright DR; Sparrow JL; Wright CL; Steiner J; Fox KM
Cardiovasc Drugs Ther; 1994 Apr; 8(2):193-7. PubMed ID: 7918131
[TBL] [Abstract][Full Text] [Related]
20. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
Drew BG; Kingwell BA
Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
